Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on February 26, 2020, 01:28:42 pm
-
People in historically underserved groups achieve a hepatitis C virus (HCV) cure at high rates when treated with Mavyret (glecaprevir/pibrentasvir).
Such historically underserved individuals with HCV include people who use drugs (PWUD); people with psychiatric disorders, a history of alcohol use (at least two drinks per day on average) or low adherence to HCV treatment; and people who are unemployed or have a low level of education.
Mavyret is approved to treat all genotypes of HCV.
For more...
https://www.hepmag.com/article/mavyret-cures-hep-c-high-rates-historically-underserved-groups